Cargando…

Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients

Detalles Bibliográficos
Autores principales: Delamain, M T, Miranda, E C M, Lourenço, G J, de Souza, C A, Lima, C S P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436081/
https://www.ncbi.nlm.nih.gov/pubmed/28452985
http://dx.doi.org/10.1038/bcj.2017.38
_version_ 1783237337173458944
author Delamain, M T
Miranda, E C M
Lourenço, G J
de Souza, C A
Lima, C S P
author_facet Delamain, M T
Miranda, E C M
Lourenço, G J
de Souza, C A
Lima, C S P
author_sort Delamain, M T
collection PubMed
description
format Online
Article
Text
id pubmed-5436081
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54360812017-05-25 Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients Delamain, M T Miranda, E C M Lourenço, G J de Souza, C A Lima, C S P Blood Cancer J Letter to the Editor Nature Publishing Group 2017-04 2017-04-28 /pmc/articles/PMC5436081/ /pubmed/28452985 http://dx.doi.org/10.1038/bcj.2017.38 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Delamain, M T
Miranda, E C M
Lourenço, G J
de Souza, C A
Lima, C S P
Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title_full Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title_fullStr Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title_full_unstemmed Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title_short Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
title_sort through translational prospective study, the gstp1 ile105val polymorphism emerges as prognostic marker in de novo large b-cell lymphoma patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436081/
https://www.ncbi.nlm.nih.gov/pubmed/28452985
http://dx.doi.org/10.1038/bcj.2017.38
work_keys_str_mv AT delamainmt throughtranslationalprospectivestudythegstp1ile105valpolymorphismemergesasprognosticmarkerindenovolargebcelllymphomapatients
AT mirandaecm throughtranslationalprospectivestudythegstp1ile105valpolymorphismemergesasprognosticmarkerindenovolargebcelllymphomapatients
AT lourencogj throughtranslationalprospectivestudythegstp1ile105valpolymorphismemergesasprognosticmarkerindenovolargebcelllymphomapatients
AT desouzaca throughtranslationalprospectivestudythegstp1ile105valpolymorphismemergesasprognosticmarkerindenovolargebcelllymphomapatients
AT limacsp throughtranslationalprospectivestudythegstp1ile105valpolymorphismemergesasprognosticmarkerindenovolargebcelllymphomapatients